Skip to content

The Mechanism Study of Modified Shaoyao Gancao Decoction in Regulating the RhoA/ROCK/LIMK Signaling Pathway for the Treatment of Adenomyosis

The Mechanism Study of Modified Shaoyao Gancao Decoction in Regulating the RhoA/ROCK/LIMK Signaling Pathway for the Treatment of Adenomyosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000571
Enrollment
Unknown
Registered
2024-10-18
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenomyosis

Interventions

Experimental group:Adenomyosis lesions and endometrium were collected
Control group:Endometrium collection

Sponsors

The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: In accordance with the clinical diagnosis of adenomyopathy; Age 20-50 years old; No hormones or similar drugs were used in the 3 months prior to the visit

Exclusion criteria

Exclusion criteria: Caused by other factors such as dysmenorrhea menorrhagia habitual abortion infertility uterine enlargement and malignant transformation; Those who have not been diagnosed by ultrasonography or CT or gynecological examination.

Design outcomes

Primary

MeasureTime frame
Expression of the target gene;

Secondary

MeasureTime frame
Expression of pathway-associated proteins;Pathological section;

Countries

China

Contacts

Public ContactWang Yishu

The Third Affiliated Hospital of Guangzhou University of Chinese Medicine

wys.121@163.com13249614461

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026